Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169504428> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2169504428 endingPage "766" @default.
- W2169504428 startingPage "761" @default.
- W2169504428 abstract "Elective switching of biological therapy in patients with Crohn's disease (CD) in remission is generally discouraged, given the theoretical risk of antibody formation and loss of response. The aim of this study was to assess efficacy and tolerability of adalimumab (ADA) therapy after an elective switch from infliximab (IFX) in patients with stable CD. Patients with CD with stable disease for >6 months (Harvey–Bradshaw Index ≤ 8) on IFX were eligible for this prospective, open-label single-center study. The primary endpoint was termination of ADA therapy. Disease activity (Harvey–Bradshaw Index, laboratory results) and adverse events were documented during the follow-up. We enrolled 29 patients with CD (19 women, mean age, 39 years; interquartile range, 23–58 years) who switched from IFX to ADA. At the end of the 54-week follow-up period, 72% of patients continued ADA therapy. Eight patients discontinued ADA therapy due to disease activity (n = 3), side effects (n = 4), or general symptoms (n = 1). After discontinuation of ADA, 4 patients switched back to IFX, and no infusion reactions occurred. No significant changes were observed in Harvey–Bradshaw Index scores, C-reactive protein, and leukocyte counts at 0 versus 54 weeks. Half of the patients who discontinued ADA showed an elevated baseline C-reactive protein. The majority of patients with CD (72%) continued therapy and maintained remission after an elective switch from IFX to ADA, although switching back to IFX, if required, was well tolerated. However, elective switching of anti-tumor necrosis factor therapy in stable CD should be carefully considered, given the risk of loss of response and the limited options for alternative maintenance therapies." @default.
- W2169504428 created "2016-06-24" @default.
- W2169504428 creator A5033556021 @default.
- W2169504428 creator A5057659680 @default.
- W2169504428 creator A5072837175 @default.
- W2169504428 creator A5078377172 @default.
- W2169504428 date "2013-03-01" @default.
- W2169504428 modified "2023-09-25" @default.
- W2169504428 title "Elective Switching from Infliximab to Adalimumab in Stable Crohnʼs Disease" @default.
- W2169504428 cites W1515981258 @default.
- W2169504428 cites W1990475163 @default.
- W2169504428 cites W1994020662 @default.
- W2169504428 cites W1994355952 @default.
- W2169504428 cites W2030638161 @default.
- W2169504428 cites W2038457542 @default.
- W2169504428 cites W2053830943 @default.
- W2169504428 cites W2085326056 @default.
- W2169504428 cites W2091573816 @default.
- W2169504428 cites W2104015736 @default.
- W2169504428 cites W2118422544 @default.
- W2169504428 cites W2121609590 @default.
- W2169504428 cites W2137775651 @default.
- W2169504428 cites W2142082253 @default.
- W2169504428 cites W2171341132 @default.
- W2169504428 doi "https://doi.org/10.1097/mib.0b013e3182802ae1" @default.
- W2169504428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23446337" @default.
- W2169504428 hasPublicationYear "2013" @default.
- W2169504428 type Work @default.
- W2169504428 sameAs 2169504428 @default.
- W2169504428 citedByCount "15" @default.
- W2169504428 countsByYear W21695044282014 @default.
- W2169504428 countsByYear W21695044282015 @default.
- W2169504428 countsByYear W21695044282016 @default.
- W2169504428 countsByYear W21695044282017 @default.
- W2169504428 countsByYear W21695044282020 @default.
- W2169504428 countsByYear W21695044282021 @default.
- W2169504428 crossrefType "journal-article" @default.
- W2169504428 hasAuthorship W2169504428A5033556021 @default.
- W2169504428 hasAuthorship W2169504428A5057659680 @default.
- W2169504428 hasAuthorship W2169504428A5072837175 @default.
- W2169504428 hasAuthorship W2169504428A5078377172 @default.
- W2169504428 hasBestOaLocation W21695044281 @default.
- W2169504428 hasConcept C119060515 @default.
- W2169504428 hasConcept C126322002 @default.
- W2169504428 hasConcept C141071460 @default.
- W2169504428 hasConcept C188816634 @default.
- W2169504428 hasConcept C197934379 @default.
- W2169504428 hasConcept C203092338 @default.
- W2169504428 hasConcept C2777138892 @default.
- W2169504428 hasConcept C2778260677 @default.
- W2169504428 hasConcept C2778375690 @default.
- W2169504428 hasConcept C2778715236 @default.
- W2169504428 hasConcept C2779134260 @default.
- W2169504428 hasConcept C2779280984 @default.
- W2169504428 hasConcept C2780132546 @default.
- W2169504428 hasConcept C2781312054 @default.
- W2169504428 hasConcept C535046627 @default.
- W2169504428 hasConcept C71924100 @default.
- W2169504428 hasConcept C90924648 @default.
- W2169504428 hasConceptScore W2169504428C119060515 @default.
- W2169504428 hasConceptScore W2169504428C126322002 @default.
- W2169504428 hasConceptScore W2169504428C141071460 @default.
- W2169504428 hasConceptScore W2169504428C188816634 @default.
- W2169504428 hasConceptScore W2169504428C197934379 @default.
- W2169504428 hasConceptScore W2169504428C203092338 @default.
- W2169504428 hasConceptScore W2169504428C2777138892 @default.
- W2169504428 hasConceptScore W2169504428C2778260677 @default.
- W2169504428 hasConceptScore W2169504428C2778375690 @default.
- W2169504428 hasConceptScore W2169504428C2778715236 @default.
- W2169504428 hasConceptScore W2169504428C2779134260 @default.
- W2169504428 hasConceptScore W2169504428C2779280984 @default.
- W2169504428 hasConceptScore W2169504428C2780132546 @default.
- W2169504428 hasConceptScore W2169504428C2781312054 @default.
- W2169504428 hasConceptScore W2169504428C535046627 @default.
- W2169504428 hasConceptScore W2169504428C71924100 @default.
- W2169504428 hasConceptScore W2169504428C90924648 @default.
- W2169504428 hasIssue "4" @default.
- W2169504428 hasLocation W21695044281 @default.
- W2169504428 hasLocation W21695044282 @default.
- W2169504428 hasOpenAccess W2169504428 @default.
- W2169504428 hasPrimaryLocation W21695044281 @default.
- W2169504428 hasRelatedWork W1588288904 @default.
- W2169504428 hasRelatedWork W1726928670 @default.
- W2169504428 hasRelatedWork W2169504428 @default.
- W2169504428 hasRelatedWork W2336578202 @default.
- W2169504428 hasRelatedWork W2737028833 @default.
- W2169504428 hasRelatedWork W2755604283 @default.
- W2169504428 hasRelatedWork W2771444241 @default.
- W2169504428 hasRelatedWork W2888259057 @default.
- W2169504428 hasRelatedWork W3180259494 @default.
- W2169504428 hasRelatedWork W4253209591 @default.
- W2169504428 hasVolume "19" @default.
- W2169504428 isParatext "false" @default.
- W2169504428 isRetracted "false" @default.
- W2169504428 magId "2169504428" @default.
- W2169504428 workType "article" @default.